MITOXANTRONE IN THE TREATMENT OF RELAPSED AND REFRACTORY ACUTE-LEUKEMIA

被引:0
|
作者
MOORE, JO
OLSEN, GA
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:41 / 46
页数:6
相关论文
共 50 条
  • [21] Treatment of children with relapsed and refractory acute lymphoblastic leukemia with mitoxantrone, vincristine, pegaspargase, dexamethasone, and bortezomib
    August, Keith J.
    Guest, Erin M.
    Lewing, Karen
    Hays, J. Allyson
    Gamis, Alan S.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (03)
  • [22] Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory acute lymphoblastic leukemia in adults.
    Krawczyk, M
    Giebel, S
    Jakubas, B
    Cioch, M
    Palynyczko, G
    Holowiecki, J
    BLOOD, 2003, 102 (11) : 883A - 883A
  • [23] MITOXANTRONE IN PATIENTS WITH ACUTE-LEUKEMIA IN RELAPSE
    PACIUCCI, PA
    OHNUMA, T
    CUTTNER, J
    SILVER, RT
    HOLLAND, JF
    CANCER RESEARCH, 1983, 43 (08) : 3919 - 3922
  • [24] TREATMENT OF REFRACTORY ACUTE-LEUKEMIA WITH ACLACINOMYCIN-A
    TAKAHASHI, I
    HARA, M
    ADACHI, T
    TAKAOKA, K
    SAKANO, M
    LAI, M
    KOHI, F
    YORIMITSU, S
    TOKIOKA, M
    KITAJIMA, K
    KIMURA, I
    SANADA, H
    ACTA MEDICA OKAYAMA, 1980, 34 (05) : 349 - 354
  • [25] TREATMENT OF REFRACTORY ACUTE-LEUKEMIA WITH ACLACINOMYCIN-A
    ROWE, JM
    CHANG, AYC
    BENNETT, JM
    BONE MARROW TRANSPLANTATION, 1989, 4 : 47 - 48
  • [26] MITOXANTRONE AND CONSTANT INFUSION ETOPOSIDE FOR RELAPSED AND REFRACTORY ACUTE MYELOCYTIC-LEUKEMIA
    PACIUCCI, PA
    DAVIS, RB
    HOLLAND, JF
    MARTELO, O
    SCHIFFER, CA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (06): : 516 - 519
  • [27] Efficacy and safety of mitoxantrone and etoposide (ME) in refractory and relapsed acute nonlymphocytic leukemia
    Pourtsidis, AG
    Baka, M
    Stasinopoulou, A
    Varvoutsi, M
    Paidoussi, C
    Bouhoutsou, D
    Kosmidis, HV
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1998, 5 (01): : 7 - 11
  • [28] TREATMENT OF RELAPSED AND REFRACTORY ACUTE-LEUKEMIA WITH HIGH-DOSE CYTOSINE-ARABINOSIDE AND ETOPOSIDE
    GORE, M
    POWLES, R
    LAKHANI, A
    MILAN, S
    MAITLAND, J
    GOSS, G
    NANDI, A
    PERREN, T
    FORGESON, G
    TRELEAVEN, J
    ZUIABLE, A
    PORTA, F
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 (06) : 373 - 376
  • [29] CONTINUOUS INFUSION CHEMOTHERAPY WITH EPIRUBICIN AND VINCRISTINE IN RELAPSED AND REFRACTORY ACUTE-LEUKEMIA
    LISO, V
    SPECCHIA, G
    PAVONE, V
    CAPALBO, S
    DIONE, R
    ACTA HAEMATOLOGICA, 1990, 83 (03) : 116 - 119
  • [30] Phase I trial of bortezomib, mitoxantrone and etoposide in relapsed/refractory acute leukemia
    Filicko-O'Hara, J.
    Mookerjee, B.
    Carabasi, M. H.
    Besa, E.
    Wagner, J. L.
    Flomenberg, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)